Home » Topics » BioWorld Science

BioWorld Science
RSS

Daiichi Sankyo profiles highlights of fourth quarter of fiscal 2017

May 4, 2018

Coherus BioSciences announces re-submission of BLA for CHS-1701

May 4, 2018

Azitra raises new financing to advance pipeline

May 4, 2018

Refuge Biotechnologies completes series B financing

May 4, 2018

FDA grants orphan drug designation to BN-Brachyury as treatment for chordoma

May 4, 2018

FDA advisory committee votes to recommend Siga's Tpoxx smallpox treatment

May 3, 2018

Heptares Therapeutics divulges novel M1 and/or M4 receptor agonists

May 3, 2018

Novel mutant IDH inhibitors presented by Isocure Biosciences

May 3, 2018

TES Pharma discovers ACMSD inhibitors

May 3, 2018

Mission Therapeutics patents USP30 inhibitors

May 3, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...